Novel Variants of Respiratory Syncytial Virus A ON1 Associated With Increased Clinical Severity of Bronchiolitis.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
16 06 2020
Historique:
received: 14 11 2019
accepted: 06 02 2020
pubmed: 8 2 2020
medline: 24 2 2021
entrez: 8 2 2020
Statut: ppublish

Résumé

A study of respiratory syncytial virus-A (RSV A) genotype ON1 genetic variability and clinical severity in infants hospitalized with bronchiolitis over 6 epidemic seasons (2012-2013 to 2017-2018) was carried out. From prospectively enrolled term infants hospitalized for bronchiolitis, samples positive for RSV A ON1 (N = 139) were sequenced in the second half of the G gene. Patients' clinical data were obtained from medical files and each infant was assigned a clinical severity score. ANOVA comparison and adjusted multinomial logistic regression were used to evaluate clinical severity score and clinical parameters. The phylogenetic analysis of 54 strains showed 3 distinct clades; sequences in the last 2 seasons differed from previous seasons. The most divergent and numerous cluster of 2017-2018 strains was characterized by a novel pattern of amino acid changes, some in antigenic sites. Several amino acid changes altered predicted glycosylation sites, with acquisition of around 10 new O-glycosylation sites. Clinical severity of bronchiolitis increased in 2016-2017 and 2017-2018 and changed according to the epidemic seasons only. Amino acid changes in the hypervariable part of G protein may have altered functions and/or changed its immunogenicity, leading to an impact on disease severity.

Sections du résumé

BACKGROUND
A study of respiratory syncytial virus-A (RSV A) genotype ON1 genetic variability and clinical severity in infants hospitalized with bronchiolitis over 6 epidemic seasons (2012-2013 to 2017-2018) was carried out.
METHODS
From prospectively enrolled term infants hospitalized for bronchiolitis, samples positive for RSV A ON1 (N = 139) were sequenced in the second half of the G gene. Patients' clinical data were obtained from medical files and each infant was assigned a clinical severity score. ANOVA comparison and adjusted multinomial logistic regression were used to evaluate clinical severity score and clinical parameters.
RESULTS
The phylogenetic analysis of 54 strains showed 3 distinct clades; sequences in the last 2 seasons differed from previous seasons. The most divergent and numerous cluster of 2017-2018 strains was characterized by a novel pattern of amino acid changes, some in antigenic sites. Several amino acid changes altered predicted glycosylation sites, with acquisition of around 10 new O-glycosylation sites. Clinical severity of bronchiolitis increased in 2016-2017 and 2017-2018 and changed according to the epidemic seasons only.
CONCLUSIONS
Amino acid changes in the hypervariable part of G protein may have altered functions and/or changed its immunogenicity, leading to an impact on disease severity.

Identifiants

pubmed: 32031626
pii: 5730044
doi: 10.1093/infdis/jiaa059
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102-110

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Fabio Midulla (F)

Department of Pediatrics, Sapienza University, Rome, Italy.

Greta Di Mattia (G)

Department of Pediatrics, Sapienza University, Rome, Italy.

Raffaella Nenna (R)

Department of Pediatrics, Sapienza University, Rome, Italy.

Carolina Scagnolari (C)

Virology Laboratory, Department of Molecular Medicine, Sapienza University,Rome, Italy.

Agnese Viscido (A)

Virology Laboratory, Department of Molecular Medicine, Sapienza University,Rome, Italy.

Giuseppe Oliveto (G)

Virology Laboratory, Department of Molecular Medicine, Sapienza University,Rome, Italy.

Laura Petrarca (L)

Department of Pediatrics, Sapienza University, Rome, Italy.

Antonella Frassanito (A)

Department of Pediatrics, Sapienza University, Rome, Italy.

Serena Arima (S)

Department of Methods and Models in Economics, the Territory and Finance, Sapienza University, Rome, Italy.

Guido Antonelli (G)

Virology Laboratory, Department of Molecular Medicine, Sapienza University,Rome, Italy.

Alessandra Pierangeli (A)

Virology Laboratory, Department of Molecular Medicine, Sapienza University,Rome, Italy.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH